These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32769317)

  • 1. Relationship between disease severity and fetuin-A levels in patients with psoriasis.
    Shehata WA; Basha MA; Gayed IM; Elhagary SB
    Indian J Dermatol Venereol Leprol; 2020; 86(5):586-588. PubMed ID: 32769317
    [No Abstract]   [Full Text] [Related]  

  • 2. The levels of serum pentraxin3, CRP, fetuin-A, and insulin in patients with psoriasis.
    Uysal S; Yılmaz FM; Karatoprak K; Artüz F; Cumbul NU
    Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3453-8. PubMed ID: 25491620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Visfatin, Fetuin-A, and Pentraxin 3 Levels in Patients With Psoriasis and Their Relation to Disease Severity.
    Okan G; Baki AM; Yorulmaz E; Doğru-Abbasoğlu S; Vural P
    J Clin Lab Anal; 2016 Jul; 30(4):284-9. PubMed ID: 25867925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Serum Fetuin-A Levels and Carotid Intima-media Thickness in Turkish Patients with Mild to Moderate Psoriasis. A Case-control Study.
    Uyar B; Akyildiz M; Solak A; Genc B; Saklamaz A
    Acta Dermatovenerol Croat; 2015; 23(3):171-7. PubMed ID: 26476900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study.
    Ju H; Zhou Z; Sun M; Chen H
    Endocrine; 2017 Oct; 58(1):190-193. PubMed ID: 28779425
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular biomarkers in patients with psoriasis.
    Gerdes S; Osadtschy S; Buhles N; Baurecht H; Mrowietz U
    Exp Dermatol; 2014 May; 23(5):322-5. PubMed ID: 24660963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.
    Zhao ZW; Lin CG; Wu LZ; Luo YK; Fan L; Dong XF; Zheng H
    Biomarkers; 2013 Mar; 18(2):160-4. PubMed ID: 23410047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble Receptor for Advanced Glycation End Products: A Novel Biomarker for Psoriasis Severity with Therapeutic Implications?
    Batycka-Baran A; Baran W; Nowicka-Suszko D; Szepietowski JC
    Acta Derm Venereol; 2018 Aug; 98(8):797-798. PubMed ID: 29963680
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum fetuin-A levels are inversely associated with clinical severity in patients with primary knee osteoarthritis.
    Xiao J; Wang XR; Hu KZ; Li MQ; Chen JW; Ma T; Li ZC
    Biomarkers; 2013 Feb; 18(1):51-4. PubMed ID: 23066960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between dietary factors and plasma fetuin-A concentrations in the general population.
    Nimptsch K; Janke J; Pischon T; Linseisen J
    Br J Nutr; 2015 Oct; 114(8):1278-85. PubMed ID: 26316198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fetuin-A levels in patients with systolic heart failure.
    Keçebaş M; Güllülü S; Sağ S; Beşli F; Açikgöz E; Sarandöl E; Aydinlar A
    Acta Cardiol; 2014 Aug; 69(4):399-405. PubMed ID: 25181915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
    Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
    Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical atherosclerosis and fetuin-A plasma levels in essential hypertensive patients.
    Guarneri M; Geraci C; Incalcaterra F; Arsena R; Mulè G; Vaccaro F; Luna C; Cerasola G; Cottone S
    Hypertens Res; 2013 Feb; 36(2):129-33. PubMed ID: 22972556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum angiopoietin-2 level as a potential biomarker in psoriasis vulgaris.
    Takahashi T; Asano Y; Shibata S; Tada Y; Sato S
    J Dermatol; 2017 Feb; 44(2):205-206. PubMed ID: 28497874
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum fetuin-A levels inversely correlate with the severity of arterial calcification in patients with chronic lower extremity atherosclerosis without renal disease.
    Szeberin Z; Fehérvári M; Krepuska M; Apor A; Rimely E; Sarkadi H; Széplaki G; Prohászka Z; Kalabay L; Acsády G
    Int Angiol; 2011 Oct; 30(5):474-50. PubMed ID: 21804488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative correlation between fetuin-A and indices of vascular disease in systemic lupus erythematosus patients with and without lupus nephritis.
    Abdel-Wahab AF; Fathy O; Al-Harizy R
    Arab J Nephrol Transplant; 2013 Jan; 6(1):11-20. PubMed ID: 23282228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucine-rich α-2 glycoprotein is an innovative biomarker for psoriasis.
    Nakajima H; Serada S; Fujimoto M; Naka T; Sano S
    J Dermatol Sci; 2017 May; 86(2):170-174. PubMed ID: 28179066
    [No Abstract]   [Full Text] [Related]  

  • 18. Association of mitral annular calcification with fetuin-A levels.
    Ağıllı M; Aydın FN; Çaycı T; Kurt YG
    Anatol J Cardiol; 2015 Jan; 15(1):83-4. PubMed ID: 25550259
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum zinc and copper levels and Cu: Zn ratio in psoriasis.
    Nigam PK
    Indian J Dermatol Venereol Leprol; 2005; 71(3):205-6. PubMed ID: 16394416
    [No Abstract]   [Full Text] [Related]  

  • 20. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
    Haukeland JW; Dahl TB; Yndestad A; Gladhaug IP; Løberg EM; Haaland T; Konopski Z; Wium C; Aasheim ET; Johansen OE; Aukrust P; Halvorsen B; Birkeland KI
    Eur J Endocrinol; 2012 Mar; 166(3):503-10. PubMed ID: 22170794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.